Abstract
The article is review of preclinical and clinical efficacy and safety of celecoxib and rofecoxib. Rofecoxib and celecoxib are the first specific cyclooxygenase-2 inhibitors on the market of nonsterpoidal anti-inflammatory drugs.
The article is review of preclinical and clinical efficacy and safety of celecoxib and rofecoxib. Rofecoxib and celecoxib are the first specific cyclooxygenase-2 inhibitors on the market of nonsterpoidal anti-inflammatory drugs.